Suchergebnisse - "Minckwitz, Gunter von"

PubPharm (62)

1

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients : A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group

enthalten in: Cancers | 2023

von Thomssen, C. | Vetter, M. | Kantelhardt, E. | +17

2

Palbociclib for residual high-risk invasive HR-positive and HER2-negative early breast cancer : the Penelope-B trial

enthalten in: Journal of clinical oncology | April 1, 2021

von Loibl, S. | Marmé, F. | Martin, M. | +24

3

Trastuzumab emtansine for residual invasive HER2-positive breast cancer

enthalten in: The New England journal of medicine | 2019

von Minckwitz, G. | Huang, C. | Mano, M. | +26

4

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

enthalten in: Anti-cancer drugs | APR 2019

von Bischoff, J. | Barinoff, J. | Mundhenke, C. | +18

5

Ten-year results of intense dose-dense chemotherapy show superior survival compared to a conventional schedule in high-risk primary breast Cancer : final results of AGO phase III iddEPC trial

enthalten in: Annals of oncology | 2018

von Möbus, V. | Jackisch, C. | Lueck, H. | +15

6

Risk assessment after neoadjuvant chemotherapy in luminal breast cancer using a clinicomolecular predictor

enthalten in: Clinical cancer research | April 4, 2018

von Loibl, S. | Weber, K. | Huober, J. | +14

7

Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer : secondary analysis of the GeparSixto randomized clinical trial

enthalten in: JAMA oncology | 2017

von Hahnen, E. | Lederer, B. | Hauke, J. | +25

8

Relationship of omission of adjuvant radiotherapy to outcomes of locoregional control and disease-free survival in patients with or without pCR after neoadjuvant chemotherapy for breast cancer : a meta-analysis on 3481 patients from the Gepar-trials

enthalten in: Journal of clinical oncology | January 31, 2017

von Krug, D. | Lederer, B. | Debus, J. | +13

9

Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area : results of the prospectively randomized GAIN study

enthalten in: Annals of oncology | 8 August 2016

von Furlanetto, J. | Eiermann, W. | Marmé, F. | +13

10

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer : the phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)

enthalten in: European journal of cancer | 17 June 2016

von Minckwitz, G. | Rezai, M. | Tesch, H. | +16

1
2
3
4
5
6
7
Nächster »
[7]